Xenotransplantation using pigs as the transplant source holds great promise to resolve the severe shortage of human organ donors. Although stem-cell-derived organ and tissue regeneration have a potential to solve this as well for the future, it still remains as very early experimental phase. Likewise, artificial organs and mechanical devices have been simply used for bridge therapy to transplant. Therefore, xenotransplantation might provide the most imminent solution to the scarcity of human organ donors. In the last two decades, major progress has been made in understanding the mechanisms of xenografts rejection, zoonotic infections including porcine endogenous retrovirus (PERV) and production of genetically engineered pigs including α1,3-galactosyltransferase-deficient pigs. With these elaborations, it is now on the threshold of first clinical application. Particularly promising first target is porcine pancreatic islet xenotransplantation. Graft survival has been prolonged to almost one year in the non-human primate study and is waiting for the development of relatively non-toxic or clinically applicable immunosuppressive or tolerance-inducing regimens. This review highlights the currently known obstacles to translate xenotransplantation into clinical therapies and the possible strategies to overcome these hurdles, as well as current status and future perspective for clinical xenotransplantaion.
). The islet yield per gram of pancreas of the ACM pigs (9,589±2,823 IEQ/g) was also significantly higher than that of the APM pigs (1,752±874 IEQ/g), AM pigs (1,931±947 IEQ/g), or YCM pigs (3,460±1,985 IEQ/g; Table 2 ). The isolation index of the ACM pigs was significantly higher than those of the AM or YCM pigs. However, the purity of the islets, as estimated by dithizone staining, was not significantly different among the experimental groups and was always more than 90%. Three donor parameters including pig body weight, age and sex, and three procurement parameters including anesthesia duration, decapsulation, and distension status were analyzed using total IEQ and IEQ/g as outcome variables Working forward analysis provided a simplified model for predicting higher islet yield. Identified variables allowed for an accuracy of 71.2% for higher IEQ/g and 83.1% for higher total IEQ. 
